(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INNOVATIVE HEMATOLOGY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

INNOVATIVE HEMATOLOGY

ST13

US500000098467889

Class

42, 44

Filing

98467889

Registration

7908410

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

08/19/2025

Trademark type

Combined

Nice classes

42, 44

Filing date

03/26/2024

Registration date

08/19/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/19/2025

Last transaction

08/19/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/01/2024

First use in commerce

06/01/2024

Drawing code

3

Owner type

99

Owner location

Indianapolis, IN, US

Examiner

MATZINGER, AMY L

Law office

N90

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a droplet design inside of which appear two curved lines and a circle. The design droplet appears next to the stacked words "INNOVATIVE HEMATOLOGY".

Holders and representatives

Holders

Innovative Hematology, Inc.

Representatives

Thomas A. Walsh Ice Miller LLP

Technical classification

Nice Classes

Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Medical research services; biomedical research services; medical research services in the field of diseases related to blood; medical research services in the field of blood disorders; pharmaceutical research services

Class 44

Medical services; medical services in the field of diseases related to blood; medical services in the field of blood disorders; pharmaceutical compounding services; preparation of prescriptions in pharmacies

Publications

History of USPTO decisions and trademark events.

30 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/19/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

08/19/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/28/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/28/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/25/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/25/2025

IUAF

USE AMENDMENT FILED

04/08/2025

EISU

TEAS STATEMENT OF USE RECEIVED

04/08/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/25/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/31/2024

PUBO

PUBLISHED FOR OPPOSITION

12/31/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/25/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/04/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/03/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/03/2024

ALIE

ASSIGNED TO LIE

12/03/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

10/17/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

10/10/2024

GNSL

LETTER OF SUSPENSION E-MAILED

10/10/2024

CNSL

SUSPENSION LETTER WRITTEN

10/10/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/09/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/08/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/08/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/07/2024

GNRT

NON-FINAL ACTION E-MAILED

10/07/2024

CNRT

NON-FINAL ACTION WRITTEN

10/07/2024

DOCK

ASSIGNED TO EXAMINER

10/04/2024

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/26/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/26/2024

NWAP

NEW APPLICATION ENTERED

03/26/2024

Continuous trademark protection

Get notified about every new filing that threatens INNOVATIVE HEMATOLOGY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.